Key result
Patients with paralytic poliomyelitis harbored rare genetic variants in genes involved in interferon signaling, viral replication, apoptosis, and autophagy, which may contribute to the clinical presentation of severe poliovirus infection.
Why the study?
The mechanisms determining progression to viremia, neuronal infection, and paralysis in the minority of poliovirus-infected patients remain unanswered, suggesting a potential genetic etiology.
Case-Control (n=32)
Genetic variants in innate immune defenses and cell death pathways may contribute to the severe clinical presentation of paralytic poliomyelitis.
Variants in innate immunity and cell death genes may predispose to paralytic polio; leaves open a genetic basis for rare progression and warrants larger validation studies.
PURPOSE: Poliovirus (PV) is one of the most studied viruses. Despite efforts to understand PV infection within the host, fundamental questions remain unanswered. These include the mechanisms determining the progression to viremia, the pathogenesis of neuronal infection and paralysis in only a minority of patients. Because of the rare disease phenotype of paralytic poliomyelitis (PPM), we hypothesize that a genetic etiology may contribute to the disease course and outcome. METHODS: We used whole-exome sequencing (WES) to investigate the genetic profile of 18 patients with PPM. Functional analyses were performed on peripheral blood mononuclear cells (PBMCs) and monocyte-derived macrophages (MdMs). RESULTS: We identified rare variants in host genes involved in interferon signaling, viral replication, apoptosis, and autophagy. Upon PV infection of MdMs, we observed a tendency toward increased viral burden in patients compared to controls, suggesting reduced control of PV infection. In MdMs from patients, the IFNβ response correlated with the viral burden. CONCLUSION: We suggest that genetic variants in innate immune defenses and cell death pathways contribute to the clinical presentation of PV infection. Importantly, this study is the first to uncover the genetic profile in patients with PPM combined with investigations of immune responses and viral burden in primary cells.
No takes yet. Share an insight, caveat, or question.
Andersen et al. (2019) conducted a case-control in Paralytic poliomyelitis (n=32). Rare genetic variants in innate immune defenses and cell death pathways vs. Healthy controls without paralytic poliomyelitis was evaluated on Identification of rare genetic variants and in vitro viral burden/interferon beta response upon poliovirus infection. Patients with paralytic poliomyelitis harbored rare genetic variants in genes involved in interferon signaling, viral replication, apoptosis, and autophagy, which may contribute to the clinical presentation of severe poliovirus infection.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: